Bioequivalence Study of Nitrofurantoin 100 mg Capsules Under Fed Conditions
Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
An open label, randomised, two-treatment, four-period, two-sequence, single-dose, crossover,
fully replicated bioavailability study on Nitrofurantoin formulations comparing
Nitrofurantoin 100 mg capsules of Ranbaxy Laboratories with Macrobid 100 mg capsules in
healthy, adult, human subjects under fed conditions